Bluejay Diagnostics BJDX Income Statement (2020-2026)

NASDAQ BJDX
$1.00 -0.03 (-3.38%)
As of: Sep 9, 2026 · 11:22 AM EDT
Reported Financials

Bluejay Diagnostics Quarterly Income Statement

Periods 24 quarters
Latest Jun 2026

Bluejay Diagnostics reported net income of -$2.32M for the quarter ended Jun 2026. This income statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.02M0.01M0.03M0.03M0.03M0.03M0.03M0.03M0.04M0.04M0.08M0.12M2.39M0.05M0.14M0.37M0.41M0.45M1.03M1.98M
Revenue & cost
Revenue
0.25M
Gross Profit
0.05M
Operating items
Research & DevelopmentR&D
0.44M0.46M0.69M0.76M1.38M1.32M1.35M1.68M1.40M1.29M1.33M1.03M0.55M0.55M0.78M0.89M0.79M0.59M0.81M1.44M
Selling, General & AdministrativeSG&A
0.45M0.82M1.32M1.20M1.28M0.96M1.18M1.07M0.96M1.10M1.09M0.86M0.81M0.93M1.10M1.10M0.83M0.88M1.13M0.91M
Other Operating ExpensesOther Opex
0.07M0.10M0.05M0.08M-0.21M0.17M0.15M0.15M-0.02M687.000.01M305.00753.00816.00
Operating ExpensesOpex
0.96M1.37M2.07M2.03M2.81M2.45M2.68M2.90M2.34M2.39M2.43M1.90M1.36M1.48M1.89M1.99M1.62M1.46M1.94M2.35M
Operating IncomeOp. Inc
-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.43M-1.90M-1.36M-1.48M-1.89M-1.99M-1.62M-1.46M-1.94M-2.35M
EBIT
-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.43M-1.90M-1.36M-1.48M-1.89M-1.99M-1.62M-1.46M-1.94M-2.35M
Non-operating items
Non Operating Interest Expenses
0.63M0.19M729.00222.00200.00187.00
Interest & Investment IncomeInt & Inv Inc
0.03M0.02M0.06M0.04M0.02M0.03M0.02M0.03M0.02M0.02M
Other Non Operating IncomeOther Non Op Inc.
0.06M0.00M0.14M0.09M0.04M-0.08M0.07M0.03M0.01M0.01M0.01M-497.00554.00579.00731.00282.00
Non Operating IncomeNon Op. Inc.
-0.24M-0.09M0.05M0.05M-0.15M0.07M0.14M0.09M0.04M0.08M0.10M-0.58M-0.12M0.05M0.02M0.03M0.02M0.03M0.02M0.03M
Net income details
EBT
-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.40M-2.51M-1.49M-1.45M-1.87M-1.96M-1.60M-1.43M-1.92M-2.32M
Profit After TaxPAT
-1.19M-1.46M-2.01M-1.94M-2.96M-2.39M-2.54M-2.81M-2.30M-2.30M-2.33M-2.48M-1.48M-1.43M-1.86M-1.96M-1.60M-1.43M-1.92M-2.32M
Income from Continuing OperationsIncome (Continuing)
-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.40M-2.51M-1.49M-1.45M-1.87M-1.96M-1.60M-1.43M-1.92M-2.32M
Consolidated Net IncomeConsol Net Inc.
-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.40M-2.51M-1.49M-1.45M-1.87M-1.96M-1.60M-1.43M-1.92M-2.32M
Income towards Parent CompanyParent Net Inc
-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.40M-2.51M-1.49M-1.45M-1.87M-1.96M-1.60M-1.43M-1.92M-2.32M
Net Income towards Common StockholdersNet Income
-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.40M-2.51M-14.71M-1.43M-1.87M-1.96M-1.60M-1.43M-1.92M-2.32M
Additional items
EPS (Basic)
-58.44-103.10-65.72-63.09-89.25-77.88-84.17-90.83-67.92-69.65-32.52-20.75-6.16-31.23-13.51-5.64-4.06-3.18-1.95-1.12
EPS (Diluted)
-96.99-103.10-65.72-63.09-89.25-77.88-84.17-90.83-67.92-69.65-32.52-20.75-6.16-31.23-13.51-5.64-4.06-3.18-1.95-1.12
Shares Outstanding
0.02M0.01M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.07M0.12M2.39M0.05M0.14M0.35M0.39M0.45M0.98M2.08M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.01M0.01M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.07M0.12M2.39M0.05M0.14M0.35M0.39M0.45M0.98M2.08M
EBITDA
-0.96M-1.37M-2.07M-1.99M-2.81M-2.45M-2.68M-2.90M-2.34M-2.39M-2.43M-1.90M-1.36M-1.48M-1.89M-1.99M-1.62M-1.46M-1.94M-2.35M
Interest ExpensesInt Expense
0.63M0.19M729.00222.00200.00187.00